Background
Male factor infertility contributes to approximately 50% of reproductive failure in couples worldwide.
- This is stated in the abstract's background framing.
- The paper is a narrative critical review, not a primary study.
- Evidence was synthesized from systematic reviews, meta-analyses, randomized controlled trials, and clinical practice guidelines.
Results
The majority of identifiable etiologies of male infertility show some degree of reversibility.
- The review examined hormonal, surgical, pharmacological, lifestyle, and drug-induced etiologies.
- It distinguished reversible from irreversible causes.
Results
Varicocele, present in 25-40% of infertile men, is associated with natural pregnancy rates of 30-40% after varicocelectomy.
- Prevalence of 25-40% refers to infertile men.
- Natural pregnancy rate after varicocelectomy was reported as 30-40%.
Results
Hypogonadotropic hypogonadism responds to gonadotropin therapy, with spermatogenesis induced in 90-95% of cases.
- The treatment is gonadotropin therapy.
- The outcome is induction of spermatogenesis in 90-95% of cases.
Results
Obstructive azoospermia achieves ductal patency rates of 85-97% with microsurgical reconstruction.
- The reported range is 85-97% patency.
- Surgery is microsurgical reconstruction.
Results
Male accessory gland inflammation is reversible with prompt antibiotic therapy.
- Reversibility is tied to prompt treatment with antibiotics.
Results
Spermiotoxic drug exposures show variable reversibility depending on the agent and duration of exposure.
- Agents discussed include anabolic-androgenic steroids, sulfasalazine, and chemotherapy.
- Reversibility varies by agent and duration of exposure.
Results
Normogonadotropic normotestosteronemic oligozoospermia is a commonly encountered phenotype that may respond to empirical medical therapy.
- The abstract describes it as commonly encountered.
- Response to empirical medical therapy is described as possible ('may respond').
Results
Lifestyle modifications demonstrate measurable benefits in selected patients.
- Benefits were described as occurring in selected patients, not universally.
Results
Klinefelter syndrome, Y-chromosome AZFa/b microdeletions, and severe post-chemotherapy damage are irreversible causes of male infertility.
- These were identified as the main irreversible etiologies.
Conclusions
Systematic andrological evaluation, including comprehensive drug history, is essential to identify treatable causes and guide management.
- Drug history is highlighted because drug-induced causes may be reversible.